Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8378108 Apoptosis signal-regulating kinase inhibitors

Patent 8378108 was granted and assigned to Gilead Sciences on February, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8378108

Date of Patent

February 19, 2013

Patent Application Number

12834673

Date Filed

July 12, 2010

Patent Citations Received

‌

US Patent 12121022 Stabilization of thrombocytes at ambient temperatures

‌

US Patent 11834436 Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

‌

US Patent 12018017 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

‌

US Patent 12089588 Reduction of erythrocyte sedimentation rate

‌

US Patent 11672247 Stabilization of thrombocytes at ambient temperatures

Patent Primary Examiner

‌

Dennis Heyer

Patent abstract

The present invention relates to compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8378108 Apoptosis signal-regulating kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API